跳至主要内容
临床试验/NCT01447719
NCT01447719已完成3 期

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Avid Radiopharmaceuticals23 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2010年3月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
110
试验地点
23
主要终点
Sensitivity Analysis in All Autopsy Population

研究概览

简要总结

This study is designed to test the relationship between measurements of brain amyloid using florbetapir F 18 PET imaging and true levels of amyloid plaque density as measured by histopathological assessment. The study will address the following specific aims:

  1. To expand the number of subjects included in the A07 (NCT00857415) trial correlation analysis (measuring the correlation between the global visual rating of brain amyloid plaque density on an independent blinded read of the florbetapir F 18 PET scan and the cortical amyloid plaque density at autopsy as assessed by histopathology for subjects in the autopsy cohort).
  2. To determine the sensitivity and specificity of an independent blinded visual read assessment of the florbetapir F 18 PET scan (Aβ+ or Aβ-) versus the final blinded neuropathological assessment made at autopsy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects are enrolled in this study if they:
  • Met entrance criteria and were enrolled and imaged in trial 18F-AV-45-A07 (NCT00857415)
  • Gave informed consent for the 18F-AV-45-A07 (NCT00857415) study procedures and brain donation consistent with the legal requirements of the State in which they are enrolled and the State in which they die
  • Consent to participate in the 18F-AV-45-A16 (NCT01447719) extension protocol, if required by the IRB
  • Reconfirm their consent to a research brain autopsy, if required by the IRB.

排除标准

  • 未提供

结局指标

主要结局

Sensitivity Analysis in All Autopsy Population

时间窗: at autopsy within 24 months of florbetapir PET scan

Sensitivity of florbetapir-PET scan to detect moderate to frequent amyloid plaques. Plaque density was calculated using CERAD (Consortium to Establish a Registry for AD) criteria. Florbetpir-PET scans were read by five independent readers blinded to clinical information using the binary read method (amyloid positive/negative).

Specificity Analysis in All Autopsy Population

时间窗: at autopsy within 24 months of florbetapir PET scan

Specificity of florbetapir-PET scan to detect moderate to frequent amyloid plaques. Plaque density was calculated using CERAD criteria. Florbetpir-PET scans were read by five independent readers blinded to clinical information using the binary read method (amyloid positive/negative).

Correlation of Florbetapir-PET Image and Amyloid Plaque Density

时间窗: at autopsy within 24 months of florbetapir PET scan

Spearman's rank order correlation of the median visual read of the florbetapir-PET image and the amyloid plaque density assessed post-mortem by quantitative immunohistochemistry (IHC) averaged across 6 brain regions (precuneus, parietal cortex, frontal cortex, temporal cortex, posterior cingulate, anterior cingulate). Spearman's rank order correlation ranges from -1 to +1. A value of -1 indicates perfect negative correlation, and a value of +1 indicates a perfect positive correlation.

次要结局

  • Sensitivity Analysis in Subjects With Autopsy Within 1 Year of Scan(at autopsy within 12 months of florbetapir PET scan)
  • Specificity Analysis in Subjects With Autopsy Within 1 Year of Scan(at autopsy within 12 months of florbetapir PET scan)

研究者

发起方
Avid Radiopharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验